BCL-2 but not FOXP1, is an adverse risk factor in immunochemotherapy treated non-germinal center diffuse large B-cell lymphomas
Autori principali: | , , , , , |
---|---|
Natura: | Conference item |
Pubblicazione: |
2008
|
Search Result 1
Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.
Pubblicazione 2009
Journal article